Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Telo Genomics Corp (OP: TDSGF ) 0.1577 +0.0061 (+4.02%) Streaming Delayed Price Updated: 12:28 PM EDT, Jun 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 600 Open 0.1332 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1516 Today's Range 0.1332 - 0.1577 52wk Range 0.0795 - 0.2372 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News EXCLUSIVE: Telo Genomics' Smoldering Multiple Myeloma Prognostic Test Predicts Risk Of Disease Progression, Study Shows May 30, 2024 American Journal of Hematology accepts Telo Genomics' study on TeloViewSMM, a prognostic test for smoldering multiple myeloma. The test showed 85% positive and 73% negative predictive values, offering... Via Benzinga Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 January 30, 2024 EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END Via FinancialNewsMedia Performance YTD -17.74% -17.74% 1 Month +21.78% +21.78% 3 Month +90.23% +90.23% 6 Month +3.96% +3.96% 1 Year -21.15% -21.15% More News Read More Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation October 26, 2023 Via Newsfile Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 January 30, 2024 From FN Media Group LLC Via GlobeNewswire Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 October 17, 2023 Via FinancialNewsMedia Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved October 17, 2023 Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting October 12, 2023 Via FinancialNewsMedia Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study September 14, 2022 Via Newsfile Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
